Financial Perspectives, Inc Genmab A/S Transaction History
Financial Perspectives, Inc
- $271 Billion
- Q2 2024
A detailed history of Financial Perspectives, Inc transactions in Genmab A/S stock. As of the latest transaction made, Financial Perspectives, Inc holds 1,333 shares of GMAB stock, worth $31,178. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,333
Previous 1,333
-0.0%
Holding current value
$31,178
Previous $39.9 Million
15.98%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding GMAB
# of Institutions
232Shares Held
48.5MCall Options Held
6.8KPut Options Held
27.6K-
Alliancebernstein L.P. New York, NY15.2MShares$356 Million0.14% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$119 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.23MShares$98.9 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.77MShares$64.7 Million0.4% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$54 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $15.4B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...